Illegal Activity
none
Blackmail
none
Date
2014-05-08
Document Type
financial_report
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:43
Summary
This document is a financial report detailing the portfolio holdings of various biotech stocks as of May 8, 2014. It includes information such as trade dates, quantities, current prices, unit costs, market values, and unrealized gains/losses for each stock.
Metadata
- Subject
- Portfolio Holdings
- Sender
- —
- Recipients
- —
- Document ID
- DB-SDNY-0101837 SDNY_GM_00248021
- Date
- 2014-05-08
Financial Information
Amounts:12.178.44608,500.00422,214.00186,286.00285.28119.55597,661.60250,454.95347,206.6524.1327.51603,250.00687,663.50(84,413.50)79.3679.41642,816.00643,204.00(388.00)2,452,227.602,003,536.45448,691.156.7617.60111,776.60290,997.40(179,220.80)
Assets:
- SANGAMO BIOSCIENCES
- BIOGEN
- FOUNDATION MEDICINE
- GILEAD SCIENCES INC
- ARIAD PHARMACEUTICALS
Raw Analysis JSON
click to expand
Themes
Financial transactions/money flow
Organizations 5
SANGAMO BIOSCIENCESBIOGENFOUNDATION MEDICINEGILEAD SCIENCES INCARIAD PHARMACEUTICALS
Text Analysis
- Tone
- Informative
- Purpose
- To provide a snapshot of portfolio holdings, including trade dates, quantities, prices, costs, market values, and unrealized gains/losses.
- Significance
- This document provides a financial overview of specific biotech stocks held in a portfolio as of May 8, 2014.
File Info
- File Name
- EFTA01447256.txt
- Dataset
- dataset_10
- Type
- Text
- Model
- gemini-2.0-flash-001
- Processed
- 2026-02-07T18:43:35.854114
- DOJ Source
- View on DOJ